Meeting
2022 ASCO Genitourinary Cancers Symposium
External beam radiation therapy with or without brachytherapy boost for low PSA, high-grade prostate cancer.
Authors
Benjamin Walker Fischer-Valuck
Springfield Clinic, Springfield, IL
Benjamin Walker Fischer-Valuck , Brian Christopher Baumann , Vishal Ramesh Dhere , Randall Brenneman , Hiram Alberto Gay , Neal Andruska , Simon A. Brown , Bruce Hershatter , Jeff M. Michalski , Sagar Anil Patel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 258)
DOI
10.1200/JCO.2022.40.6_suppl.258
Abstract #
258
Poster Bd #
L8
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Proliferation index and survival in men with prostate cancer starting long-term androgen deprivation therapy in the STAMPEDE clinical trial.
First Author: Larissa Mendes
Poster
2020 Genitourinary Cancers Symposium
Quality of life outcomes from a phase III trial exploring optimal sequencing of androgen deprivation therapy with external beam radiotherapy in localized prostate cancer.
First Author: Soumyajit Roy
Poster
2020 Genitourinary Cancers Symposium
INTREPId (INTermediate Risk Erection PreservatIon Trial): A randomized trial of radiation therapy and darolutamide for prostate cancer.
First Author: Martin T. King
Poster
2020 Genitourinary Cancers Symposium
Impact of somatic SPOP (Speckle-Type POZ protein) mutation (mtSPOP) on response to systemic therapy and survival outcome in men with de novo metastatic castration-sensitive prostate cancer (d-mCSPC).
First Author: Umang Swami